作者
Eleana Bolla, Anne Grete Semb, Anne M Kerola, Eirik Ikdahl, Michelle Petri, Guillermo J Pons-Estel, George A Karpouzas, Petros P Sfikakis, Rosana Quintana, Durga Prasanna Misra, Eduardo Ferreira Borba, Ignacio Garcia-de la Torre, Tatiana V Popkova, Bahar Artim-Esen, Anne Troldborg, Hilda Fragoso-Loyo, Sofia Ajeganova, Ayten Yazici, Gustavo Aroca-Martinez, Haner Direskeneli, Manuel F Ugarte-Gil, Marta Mosca, Mohit Goyal, Elisabet Svenungsson, Carla Macieira, Alberta Hoi, Karoline Lerang, Nathalie Costedoat-Chalumeau, Angela Tincani, Erkin Mirrakhimov, Isabel Acosta Colman, Alvaro Danza, Loreto Massardo, Jelena Blagojevic, Neslihan Yılmaz, Dana Tegzová, Sule Yavuz, Cengiz Korkmaz, Eric Hachulla, Mario J Moreno Alvarez, Roberto Muñoz-Louis, Nikos Pantazis, Maria G Tektonidou, Veronica Bellomio, Ilaria Cavazzana, Nikita Khmelinskii, Odirlei Andre Monticielo, Margarita Portela Hernández, Miguel Angel Saavedra Salinas, Marina Scolnik, Ana Carolina Silva Montandon, Esin Yilmaz, Dina Zucchi
发表日期
2024/6/12
期刊
The Lancet Rheumatology
出版商
Elsevier
简介
Background
Systemic lupus erythematosus (SLE) is characterised by increased cardiovascular morbidity and mortality risk. We aimed to examine the prevalence of traditional cardiovascular risk factors and their control in an international survey of patients with systemic lupus erythematosus.
Methods
In this multicentre, cross-sectional study, cardiovascular risk factor data from medical files of adult patients (aged ≥18) with SLE followed between Jan 1, 2015, and Jan 1, 2020, were collected from 24 countries, across five continents. We assessed the prevalence and target attainment of cardiovascular risk factors and examined potential differences by country income level and antiphospholipid syndrome coexistence. We used the Systemic Coronary Risk Evaluation algorithm for cardiovascular risk estimation, and the European Society of Cardiology guidelines for assessing cardiovascular risk factor target attainment …
学术搜索中的文章
E Bolla, AG Semb, AM Kerola, E Ikdahl, M Petri… - The Lancet Rheumatology, 2024